thiazoles has been researched along with Fibromatosis, Abdominal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futamura, N; Hamada, S; Ikuta, K; Ishiguro, N; Kozawa, E; Nishida, Y; Urakawa, H | 1 |
| Ando, Y; Hamada, S; Ikuta, K; Ishiguro, N; Kozawa, E; Nishida, Y; Tsukushi, S; Urakawa, H | 1 |
2 other study(ies) available for thiazoles and Fibromatosis, Abdominal
| Article | Year |
|---|---|
CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; beta Catenin; Cell Nucleus; Child; Female; Fibromatosis, Abdominal; Fibromatosis, Aggressive; Humans; Male; Meloxicam; Middle Aged; Pilot Projects; Point Mutation; Retrospective Studies; Thiazines; Thiazoles; Treatment Outcome; Young Adult | 2014 |
Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Child; Cyclooxygenase 2 Inhibitors; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fibromatosis, Abdominal; Humans; Male; Meloxicam; Methotrexate; Middle Aged; Mutation; Retreatment; Thiazines; Thiazoles; Vinblastine; Young Adult | 2015 |